头皮蔓状动脉瘤:病例报告与系统综述
该系统综述通过检索多个数据库,汇总了242例头皮蔓状动脉瘤病例及1例索引病例。中位年龄25岁,男女比2.5:1,最常见表现为搏动性肿块(94%)。手术切除联合血管内栓塞的并发症率最低(0%),单纯栓塞并发症率(55.8%)显著高于单纯手术(9.9%)和联合治疗(0%),推荐联合治疗为最佳方案。
要点
- 头皮蔓状动脉瘤罕见,易误诊误治,搏动性肿块是最常见表现(94%)。
- 单纯血管内栓塞并发症率(55.8%)显著高于单纯手术(9.9%)和联合治疗(0%)。
- 推荐手术联合血管内栓塞作为最佳治疗方式,各方式复发率均低。
核心结论
- 头皮蔓状动脉瘤在正确识别和处理后预后良好,建议手术联合血管内栓塞为最佳治疗方式。
研究设计与样本
- 系统综述检索PUBMED、SCOPUS、OVID SP、SciELO和INFORMA数据库,关键词包括cirsoid、aneurysm、arteriovenous、malformation、scalp、vascular和fistula,纳入74篇相关论文报告242例病例,另加1例索引病例。
主要发现
- 中位就诊年龄25岁(范围1-72岁),男女比2.5:1。
- 最常见症状为搏动性肿块(94%患者),头痛(25%),耳鸣(20%)。
- 症状中位持续时间3年(6天至31年),60.2%为自发性,32.23%为外伤性,其余为医源性。
- 58.5%病例仅采用手术切除,21.6%仅采用血管内栓塞,14.5%采用两者联合。
- 血管内栓塞治疗队列并发症率(55.8%)显著高于仅手术切除队列(9.9%)(P < .00001)和联合治疗队列(0%)(P < .00001)。
临床怎么用
- 对于头皮蔓状动脉瘤,应优先考虑手术联合血管内栓塞的治疗策略,以降低并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Scalp cirsoid aneurysms are rare subcutaneous arteriovenous fistulae affecting the scalp. They can be easily misdiagnosed and mistreated. OBJECTIVE: To review reported cases of scalp cirsoid aneurysms for their incidence, etiology, clinical presentation, treatment, and outcomes using an illustrative case. METHODS: We conducted a PUBMED, SCOPUS, OVID SP, SciELO, and INFORMA search using the keywords; "cirsoid," "aneurysm," "arteriovenous," "malformation," "scalp," "vascular," and "fistula." We identified 74 pertinent papers, reporting 242 cases in addition to our reported index case. RESULTS: Median age at presentation was 25 yr (range 1-72 yr); male to female ratio was 2.5:1. The most common symptoms were a pulsatile mass (94% of patients), headaches (25%), and tinnitus (20%). The median duration of symptoms was 3 yr (6 d to 31 yr), with 60.2% occurring spontaneously, 32.23% traumatic, and the rest iatrogenic. A total of 58.5% of cases were managed with surgical excision only, 21.6% with endovascular embolization only, and 14.5% with a combination of both methods. The complication rate observed in the endovascular embolization treatment cohort (55.8%) was significantly higher than that observed in the surgical excision only cohort (9.9%) (P < .00001) and in the combined therapy cohort (0%) (P < .00001). There is a low recurrence rate after treatment irrespective of modality: surgical excision only (6.3%), endovascular embolization only (8.3%), and combined therapy (0%). CONCLUSION: Scalp cirsoid aneurysms are associated with good prognoses when recognized and managed appropriately. We suggest combining surgery with endovascular embolization as the optimum treatment modality.
引用
- Sofela A, Osunronbi T, Hettige S, et al. Scalp Cirsoid Aneurysms: Case Illustration and Systematic Review of Literature. Neurosurgery. 2020. PMID: 31384940. doi:10.1093/neuros/nyz303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。